Lonza first half profits plummet
Swiss fine chemicals producer Lonza is facing increasing pressure from emerging markets with sales of its organic and performance chemicals dropping 11 per cent in this year's first half.
News, Analysis & Insights on Nutrition, Supplements, and Health
Swiss fine chemicals producer Lonza is facing increasing pressure from emerging markets with sales of its organic and performance chemicals dropping 11 per cent in this year's first half.
DSM will wipe €200 million off the purchase price for Roche's vitamins unit, owing to the unit's recent poor performance and costs associated with the long approval process of competition authorities, said the company today.
Dutch food group Numico has sold off another of its non-core operations, days after the divestment of US direct marketing unit Unicity.
Taking oral glucosamine sulphate and chondroitin sulphate could be a safe and effective way of treating knee osteoarthritis, report a team of Belgian and French researchers.